SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-008523
Filing Date
2021-06-23
Accepted
2021-06-22 18:16:42
Documents
12
Period of Report
2021-06-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K tgtx-20210618x8k.htm   iXBRL 8-K 32687
  Complete submission text file 0001558370-21-008523.txt   154640

Data Files

Seq Description Document Type Size
2 EX-101.SCH tgtx-20210618.xsd EX-101.SCH 2700
3 EX-101.LAB tgtx-20210618_lab.xml EX-101.LAB 16174
4 EX-101.PRE tgtx-20210618_pre.xml EX-101.PRE 11167
5 EXTRACTED XBRL INSTANCE DOCUMENT tgtx-20210618x8k_htm.xml XML 4829
Mailing Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 (212) 554-4484
TG THERAPEUTICS, INC. (Filer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32639 | Film No.: 211036598
SIC: 2834 Pharmaceutical Preparations